The role of BPTF in melanoma progression and in response to BRAF-targeted therapy. [electronic resource]
Producer: 20150427ISSN:- 1460-2105
- Animals
- Antigens, Nuclear -- metabolism
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- metabolism
- Disease Progression
- Female
- Gene Dosage
- Gene Expression Regulation, Neoplastic
- Imidazoles -- pharmacology
- Immunoblotting
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Indoles -- pharmacology
- Melanoma -- drug therapy
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Molecular Targeted Therapy -- methods
- Mutation -- drug effects
- Nerve Tissue Proteins -- metabolism
- Oximes -- pharmacology
- Proto-Oncogene Proteins B-raf -- genetics
- Real-Time Polymerase Chain Reaction
- Skin Neoplasms -- drug therapy
- Sulfonamides -- pharmacology
- Transcription Factors -- metabolism
- Vemurafenib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.